A high expression of CLDN12 was found to be associated with a poor prognosis in patients with LUAD, cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), KICH and lower-grade glioma (LGG). Here, CLDN12 is linked to endocervical adenocarcinoma.